You are here: Industry Insights > Seegene

News List

Seegene to supply COVID-19 diagnostic tests worth 16 mil. GBP to Scotland, triple the sales volume seen last year prnasia
April 22, 2021
Seegene Inc., a leading biotechnology firm said it began supplying its COVID-19 diagnostic tests worth 16,209,150 GBP to Scotland under a public procurement agreement, the largest diagnostic volume seen in that region since the pandemic.
Seegene's Latest COVID-19 Test Can Simultaneously Target 4 Genes of SARS-CoV-2 and Recognize Multiple Virus Variants prnasia
March 03, 2021
Seegene said Wednesday it finished the development of the world's first-ever variant diagnostic test that can simultaneously detect COVID-19 and screen multiple virus variants, with a single multiplex real-time PCR testing.
Seegene develops world first COVID-19 variant test capable of identifying origins of virus variants prnasia
February 01, 2021
South Korea's biotechnology firm Seegene (KQ096530) said Monday it developed the world's first COVID-19 diagnostic variant test, capable of screening COVID-19 and identifying multiple mutant variations in a single reaction.
Seegene's COVID-19 test with saliva sample collection feature now available in Europe prnewswire
January 07, 2021
South Korea's biotechnology company specializing in molecular diagnostics, Seegene Inc. (KQ096530) said Tuesday that it has CE-IVD marked the saliva-based testing application for Allplex™ SARS-CoV-2 Assay and Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay ...
Seegene's COVID-19/FluA,B/RSV test with extraction-free feature now available in Europe prnasia
December 03, 2020
South Korea's biotechnology company specializing in molecular diagnostics, Seegene Inc. said Thursday that the extraction-free application of Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay is now available in Europe.
Seegene Receives Health Canada Approval for its COVID-19 Assay prnasia
April 13, 2020
Seegene, Inc. announced that Health Canada (HC) authorized an interim order which allows the import and sale in Canada of Seegene's Allplex™ 2019-nCoV Assay, a Real-time RT-PCR test for SARS-CoV-2, the novel coronavirus responsible for the COVID-19 diseas
Seegene launches KFDA Approved COVID-19 Assay prnasia
February 18, 2020
Korea Centers for Disease Control & Prevention notified Seegene Inc. (096530.KQ) that Korea Ministry of Food and Drug Safety (MFDS; Former KFDA) approved its novel coronavirus (COIVD-19) Real-time PCR assay for the Emergency Use, following the recent CE-I
Seegene establishes Brazilian subsidiary biospectrumasia
June 19, 2019
Seegene do Brasil Diagnósticos Ltda. will focus on the in vitro diagnostic (IVD) market in Latin America
Seegene develops world's first multiplex MDx assays with its AI system prnasia
January 04, 2018
sensitivity and specificity) of the assays developed by AI are equivalent to or even better than that of those manually developed," and also added, "Only four (4) days were sufficient by the AI system to successfully develop two 8-plex assays
Seegene Unlocks the Door to the Next Level of the Real-time PCR Business en-cphi.cn
April 27, 2017
Seegene Inc. (096530.KQ) announced that it is entering into more innovative and powerful business realm by developing the Second-generation Real-time PCR Technology which has been recently patented in the United States and Europe.

Previous page 1 2 Next page